111 – 120 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Which patients with Parkinson's disease participate in clinical trials? : One centre's experiences with a new cell based therapy trial (TRANSEURO)
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and Parkinson's disease - something to remember
(
- Contribution to journal › Article
-
Mark
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Neurodegenerative disorders : the Glia way forward
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens
(
- Contribution to journal › Article
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
-
Mark
The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies
(
- Contribution to journal › Article
-
Mark
The relationship between abnormalities of saccadic and manual response times in Parkinson's disease
(
- Contribution to journal › Article